Memorial Göztepe Hospital
Memorial Göztepe Hospital
Turchia, Istanbul
Dr. Ahmet Melih Ozel is a gastroenterologist at Anadolu Medical Center in Istanbul. He specializes in inflammatory bowel diseases and chronic liver conditions. He performs upper and lower gastrointestinal endoscopies. Dr. Ozel also focuses on pancreatobiliary system diseases. He works at a clinic affiliated with Johns Hopkins Medicine.
Dr. Zulfikar Polat is a gastroenterology and internal medicine specialist. He trained at Ankara Gülhane Military Medical Academy, where he completed his specialty and became an Associate Professor. He is a Professor at İstanbul Aydın University. His postgraduate experience includes Ankara Gülhane Military Medical Academy and İstanbul Aydın University. He also worked at Anadolu Medical Center, affiliated with Johns Hopkins Medicine (USA).
Clinical focus includes gastroenterology, hepato-pancreatology, inflammatory intestinal diseases, and diagnostic and interventional endoscopic procedures. Professional memberships include the Turkish Gastroenterology Association (TGD), Turkish Endoscopy Society, TÜRK EUS, ESGE, EASL, and AASLD. He has 45 national and international publications.
There is currently no absolute cure for chronic hepatitis B in Turkey or elsewhere. Turkish specialists focus on functional cures. This means achieving long-term virus suppression and surface antigen loss. These outcomes significantly reduce hisks of liver cirrhosis and cancer.
Bookimed Expert Insight: Patients often overlook that Turkish university-affiliated centers, like those where Prof. Dr. Zulfikar Polat practices, follow European Association for the Study of the Liver (EASL) protocols. This ensures treatment is identical to top European or American hospitals but often with faster access to specialists.
Patient Consensus: Patients note that reaching an undetectable viral load is a major success. They emphasize that regular blood tests are vital to prevent sudden viral rebounds.
Expect a detailed evaluation by a hepatologist or gastroenterologist in Istanbul or Bursa. The visit includes a liver scan and viral load testing to assess infection activity. You will receive a long-term monitoring or antiviral treatment plan within 2 to 3 days.
Bookimed Expert Insight: While many expect immediate medication, Turkish specialists like those at Anadolu Medical Center prioritize confirming if the virus is active first. Our data shows that doctors often wait for longitudinal trends from multiple labs before starting long-term therapy. This cautious approach prevents unnecessary lifelong medication for patients in the inactive carrier phase.
Patient Consensus: Patients note that consultations can feel efficient but quick, so bringing a written list of questions is helpful. Many emphasize that having previous lab results handy is vital for the doctor to see how the virus has behaved over time.
Chronic Hepatitis B treatment in Turkey usually requires long-term management lasting several years or a lifetime. Antiviral medications suppress the virus indefinitely. Immune modulators like interferon typically involve shorter courses of 6 to 12 months. Regular monitoring occurs every 3 to 12 months.
Bookimed Expert Insight: Turkish gastroenterology centers like Anadolu Medical Center operate in affiliation with Johns Hopkins Medicine. These facilities utilize advanced 512-slice CT and 3 Tesla MRI for precise liver monitoring. Accessing professors like Dr. Zulfikar Polat ensures your long-term protocol aligns with the latest European Association for the Study of the Liver (EASL) guidelines.
Patient Consensus: Patients emphasize that treatment is a marathon rather than a quick cure. They highlight the importance of never stopping medication abruptly to avoid dangerous viral flares.
Turkish hospitals provide extensive expertise in chronic Hepatitis B management due to high regional prevalence. Specialists manage over 600,000 cases annually across major centers. Facilities like Anadolu Medical Center follow standardized protocols and utilize advanced tools like AI-supported 3 Tesla MRI for precise liver monitoring.
Bookimed Expert Insight: Turkish gastroenterology departments demonstrate exceptional depth by employing dual-specialized professors. Dr. Zulfikar Polat and Dr. Ahmet Melih Ozel are both professors with military medical academy backgrounds. This specific training path in Turkey indicates a high-volume clinical environment and rigorous quality standards.
Patient Consensus: Patients note that major cities like Istanbul offer the most reliable access to English-speaking specialists and comprehensive lab monitoring. Most confirm that care follows a very organized protocol of viral load checks and routine antiviral management.
There is currently no permanent cure for chronic hepatitis B in Turkey or globally. Medical centres in Turkey focus on viral suppression using oral antivirals like Tenofovir. These treatments prevent liver damage and cirrhosis. Clinical research units in Istanbul actively participate in global functional cure trials.
Bookimed Expert Insight: Turkish gastroenterologists at top-tier centres often hold memberships in European and American liver associations. Specialists such as Dr Zulfikar Polat maintain affiliations with institutions like Johns Hopkins Medicine. This means patients receive care that strictly aligns with the latest international hepatology protocols.
Patient Consensus: Patients note that the focus in Turkey is long-term viral suppression rather than a cure. Experience shows that infectious disease screening is strict, especially when patients seek other elective surgeries.
Chronic Hepatitis B treatment in Turkey focuses on long-term viral suppression. It uses high-potency oral antiviral medications. Specialists use Tenofovir or Entecavir to control infection and prevent liver scarring. Turkish gastroenterologists also use Fibroscan technology to assess liver health without invasive biopsies.
Bookimed Expert Insight: Turkish gastroenterologists often hold memberships in the European Association for the Study of the Liver (EASL). Prof. Dr Zulfikar Polat at Anadolu Medical Center works in affiliation with Johns Hopkins Medicine. These international links mean patients receive treatments that strictly follow the latest global clinical protocols.
Patient Consensus: Patients note that Hepatitis B requires long-term medication rather than a quick cure. Carrying translated viral load and ultrasound results to Turkey helps doctors start the correct treatment immediately.
Top Turkish centres for chronic hepatitis B treatment include Istanbul's Anadolu Medical Center and Medipol Bahçelievler University Hospital. These facilities provide diagnostics like FibroScan and viral load testing. Leading hepatologists there manage long-term antiviral therapy to prevent liver damage and cancer.
Bookimed Expert Insight: Anadolu Medical Center stands out. Its specialists, like Prof. Dr. Zulfikar Polat, have postgraduate experience with Johns Hopkins Medicine. This connection means treatment plans for complex viral hepatitis cases align with leading international protocols. Australian patients benefit from this expertise. They avoid the long specialist wait times often found at home.
Patient Consensus: Patients note that managing chronic HBV requires consistent medical supervision. It also requires approved antivirals like tenofovir or entecavir. Proper medical management in Turkey is essential. Chronic hepatitis remains a primary risk factor for liver cancer.
Hepatitis B medications are widely available in Turkey. Specialists prescribe oral nucleoside and nucleotide analogs like Tenofovir (Viread, Vemlidy) and Entecavir (Baraclude). Turkey uses these high-potency drugs to suppress the virus while minimising resistance. Treatment is managed by infectious disease or hepatology specialists.
Bookimed Expert Insight: Basic antivirals are accessible across Turkey. However, seeking treatment at clinics affiliated with major American institutions provides access to the latest international clinical research. Practitioners at these centres often hold certifications from both European and American liver research associations. This dual-registration provides a higher standard of care for complex or drug-resistant cases.
Patient Consensus: Patients recommend bringing detailed viral load history. They also advise bringing previous blood work to their first appointment in Turkey. They note that private hospitals provide efficient service for foreigners. However, costs for antivirals are generally paid out-of-pocket.
Patients typically stay in Turkey for 3 to 7 days. This stay covers the initial phase of chronic Hepatitis B treatment. This period covers gastroenterologist consultations, blood tests, and liver assessments like Fibroscan. Long-term antiviral therapy then continues in Australia under local GP supervision.
Bookimed Expert Insight: Many Turkish hospitals focus on cosmetic surgery. However, choosing a centre with a dedicated hepatology unit is vital. Anadolu Medical Center is unique because it works in affiliation with Johns Hopkins Medicine. This ensures patients receive treatment protocols that align with strict international clinical standards. These standards focus on long-term liver health.
Patient Consensus: Patients note Turkey is efficient for getting a fast diagnosis and starting medication. They emphasise finding a hepatologist who understands long-term suppression rather than just short-term fixes.
Australians can typically enter Turkey for medical treatment using a standard 90-day e-Visa. This permit covers consultations and surgeries. For chronic conditions like Hepatitis B needing longer stays, patients apply for a medical residence permit. The application is made after arrival. No specific medical visa exists for short stays.
Bookimed Expert Insight: General tourists often overlook documentation. However, specialists frequently review international clinical research data. For example, Prof. Dr. Ahmet Melih Ozel at Anadolu Medical Center does this. Patients should have their Australian medical records translated into English or Turkish. This helps avoid diagnostic delays during the initial 90-day e-Visa period.
Patient Consensus: Patients note that the standard e-Visa is sufficient for initial consultations in Turkey. They suggest bringing clear documentation of their diagnosis. This should be presented during hospital admissions and follow-ups.